RHC - Ramsay Health Care Limited
ASX
->
Healthcare
->
Medical Care Facilities
Sydney,
Australia
Type: Equity
RHC price evolution
RHC
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $361.7 | $361.7 | $656.1 | |
| Short term investments | ||||
| Net receivables | $2451.6 | $0.41 | $0.28 | $0.51 |
| Inventory | $383.9 | $383.9 | $388.6 | |
| Total current assets | $3498.4 | $3.62 | $3.76 | $2.81 |
| Long term investments | $6.1 | $6.1 | $64.5 | |
| Property, plant & equipment | $10274.9 | $83.4 | $71.69 | $64.66 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $20638.1 | $87.12 | $75.55 | $67.57 |
| Current liabilities | ||||
| Accounts payable | $2966 | $6.83 | $6.8 | $12.02 |
| Deferred revenue | ||||
| Short long term debt | $513.5 | $513.5 | $486.8 | |
| Total current liabilities | $3676.1 | $8.69 | $7.62 | $12.17 |
| Long term debt | $10596.8 | $28.53 | $16.91 | $4.27 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $15147.7 | $38.17 | $24.91 | $16.82 |
| Shareholders' equity | ||||
| Retained earnings | $2473.1 | -$40.87 | -$39.04 | -$36.3 |
| Other shareholder equity | $599.5 | $0.62 | $0.63 | $0.42 |
| Total shareholder equity | $5490.4 | $5490.4 | $4823.2 | |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $656.1 | $314.2 | $1004.8 | $1503.7 |
| Short term investments | ||||
| Net receivables | $2315.6 | $2373.5 | $1813.7 | $1931.5 |
| Inventory | $388.6 | $376.8 | $409.4 | $411 |
| Total current assets | $3895.8 | $3286.7 | $5351.4 | $4060.8 |
| Long term investments | $64.5 | $283.8 | $300.4 | $328.4 |
| Property, plant & equipment | $10187.2 | $9434.6 | $8900.1 | $8925.1 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.52 | |||
| Total investments | ||||
| Total assets | $21030.2 | $19473.3 | $19324.6 | $18099.7 |
| Current liabilities | ||||
| Accounts payable | $1484.3 | $1476 | $1164.6 | $1148.6 |
| Deferred revenue | ||||
| Short long term debt | $486.8 | $397.6 | $419.9 | $380.1 |
| Total current liabilities | $3810.4 | $3725.6 | $3717.2 | $3772.9 |
| Long term debt | $11399.5 | $10301.1 | $10131.8 | $9136.9 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $16207 | $14947.1 | $15291.9 | $14347.2 |
| Shareholders' equity | ||||
| Retained earnings | $1786.7 | $1708.7 | $1659.6 | $1380.9 |
| Other shareholder equity | $635.7 | $440.1 | $426.8 | |
| Total shareholder equity | $4823.2 | $4526.2 | $4032.7 | $3752.5 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4042.55 | $4138.6 | ||
| Cost of revenue | $3556.85 | $3410 | ||
| Gross Profit | $524.85 | $728.6 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3820.15 | $1.09 | $2.24 | $3644.6 |
| Operating income | $259.25 | $494 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $33.65 | $26.1 | ||
| Interest expense | -$156.8 | -$0.75 | -$0.02 | -$125.8 |
| Net income | ||||
| Net income | $379.25 | -$1.84 | -$2.73 | $40.7 |
| Income (for common shares) | $375.25 | $46 | ||
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14963.9 | $13312.4 | $12442.6 | $11983.4 |
| Cost of revenue | $13317.1 | $11903.9 | $3465 | $3044.9 |
| Gross Profit | $1646.8 | $1408.5 | $8977.6 | $8938.5 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7817.6 | $7571.8 | ||
| Total operating expenses | $14303.6 | $12831.5 | $11346.5 | $11122.6 |
| Operating income | $660.3 | $480.9 | $1096.1 | $860.8 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $181.5 | $159.3 | $257.8 | $159.6 |
| Interest expense | -$514.2 | -$389 | ||
| Net income | ||||
| Net income | $298.1 | $274 | $449 | $284 |
| Income (for common shares) | $285.1 | $265 | $439.9 | $272.7 |
| (in millions $) | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 | 31 Jan 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$22.54 | -$16.12 | -$8.97 | -$13.7 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $26.42 | $17.57 | $5.26 | $7.58 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.68 | -$0.75 | $0.1 | -$9.41 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 31 Jan 2022 | 30 Jan 2021 |
|---|---|---|---|---|
| Net income | $298.1 | $274 | ||
| Operating activities | ||||
| Depreciation | $940.3 | $881.8 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1279.6 | $715.5 | -$0.86 | |
| Investing activities | ||||
| Capital expenditures | -$720.9 | -$708.5 | ||
| Investments | ||||
| Total cash flows from investing | -$713.8 | $30 | -$11.31 | -$0.33 |
| Financing activities | ||||
| Dividends paid | -$218.7 | -$351.9 | ||
| Sale and purchase of stock | ||||
| Net borrowings | -$3.6 | -$1037.8 | ||
| Total cash flows from financing | -$242.4 | -$1410.9 | $17.98 | $7.02 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $341.9 | -$690.6 | $4.55 | $5.83 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $415.38M |
| Revenue Q/Q | 10.50% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | 7.96% |
| ROE | N/A |
| Debt/Equity | 3.36 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.95 |
| Quick ratio | 0.85 |